Haematopoietic Stem Cells

Reliance Life Sciences is involved in developing cell therapies for cardiac, neural, orthopaedic and cartilage disorders. Diseases that can be treated by hematopoietic stem cell transplantation include Thalassemia, Fanconi's Anemia, Hurlers Syndrome, Sickle Cell Anemia, Acute Myeloid & Lymphoid Leukemias, Chronic Myeloid Leukemia, Hodgkins Lymphoma and Juvenile Myelomonocytic Leukemia.

Areas of Research

• Development of bone-marrow mesenchymal cells for treating cardiac infarcts
• Neural cells derived from cord blood mesenchymal cells for treatment of stroke
• Chondrocytes derived from bone-marrow mesenchymal cells for treatment of cartilage disorders
• Osteocytes derived from bone-marrow mesenchymal cells for treatment of bone disorders
• In vitro expansion of haematopoietic stem cells